Invivyd, Inc. (IVVD) vs Lexeo Therapeutics, Inc. (LXEO)
Invivyd, Inc. and Lexeo Therapeutics, Inc. are both Biotechnology companies. Invivyd, Inc. and Lexeo Therapeutics, Inc. are of similar size ($278.3M and $274.1M). Lexeo Therapeutics, Inc. has the higher net margin (0.00% vs −183.9%) and the higher return on invested capital (−253.5% vs −334.9%). Across the 14 metrics below, Lexeo Therapeutics, Inc. leads on 11 and Invivyd, Inc. on 3.
Valuation
Profitability
| Metric | IVVD | LXEO | Biotechnology median |
|---|---|---|---|
| Gross margin | 92.23% | 0.00% | 65.16% |
| Operating margin | (192.81%) | 0.00% | 0.00% |
| Net margin | (183.90%) | 0.00% | 0.00% |
| Free cash flow margin | (187.88%) | 0.00% | 0.00% |
| Return on equity | (95.89%) | (46.76%) | (57.72%) |
| Return on assets | (69.69%) | (40.50%) | (49.22%) |
| Return on invested capital | (334.92%) | (253.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack